| __timestamp | Amicus Therapeutics, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 34916000 |
| Thursday, January 1, 2015 | 47269000 | 36949000 |
| Friday, January 1, 2016 | 71151000 | 45240000 |
| Sunday, January 1, 2017 | 88671000 | 62416000 |
| Monday, January 1, 2018 | 127200000 | 81289000 |
| Tuesday, January 1, 2019 | 169861000 | 100359000 |
| Wednesday, January 1, 2020 | 156407000 | 105326000 |
| Friday, January 1, 2021 | 192710000 | 122356000 |
| Saturday, January 1, 2022 | 213041000 | 152848000 |
| Sunday, January 1, 2023 | 275270000 | 184259000 |
Cracking the code
In the competitive landscape of biotechnology, managing operational costs is crucial for sustained growth. Over the past decade, from 2014 to 2023, Corcept Therapeutics Incorporated and Amicus Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses.
Amicus Therapeutics has seen a remarkable increase in SG&A costs, growing by over 1,200% from 2014 to 2023. This surge reflects their aggressive expansion and investment in administrative capabilities. In contrast, Corcept Therapeutics, while also experiencing growth, has maintained a more conservative increase of approximately 430% over the same period.
This divergence highlights differing strategic priorities: Amicus's focus on rapid scaling versus Corcept's steady, controlled growth. As both companies continue to evolve, their SG&A trends offer valuable insights into their operational strategies and market positioning.
Eli Lilly and Company vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Alnylam Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.